Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 24377509)

1.

Viral hepatitis and liver cancer in Korea: an epidemiological perspective.

Yeo Y, Gwack J, Kang S, Koo B, Jung SJ, Dhamala P, Ko KP, Lim YK, Yoo KY.

Asian Pac J Cancer Prev. 2013;14(11):6227-31. Review.

2.

Hepatitis B vaccination in children: the Taiwan experience.

Ni YH, Chen DS.

Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002. Epub 2010 Jan 29.

PMID:
20116181
3.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
5.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.

6.

Hepatitis B vaccination and liver cancer mortality reduction in Korean children and adolescents.

Gwack J, Park SK, Lee EH, Park B, Choi Y, Yoo KY.

Asian Pac J Cancer Prev. 2011;12(9):2205-8.

7.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
8.

Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.

Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.

J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943. Epub 2013 Jan 8.

9.

Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.

Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.

J Gastroenterol Hepatol. 2005 May;20(5):746-51.

PMID:
15853989
10.

Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.

Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

J Med Virol. 2011 Jul;83(7):1172-7. doi: 10.1002/jmv.22095. Epub 2011 May 3.

PMID:
21541950
11.

Hepatitis B virus and cancer prevention.

Chang MH.

Recent Results Cancer Res. 2011;188:75-84. doi: 10.1007/978-3-642-10858-7_6.

PMID:
21253790
12.

Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.

Hann HW, Kim CY, London WT, Whitford P, Blumberg BS.

Int J Cancer. 1982 Jul 15;30(1):47-51.

PMID:
6288579
13.

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.

Ive P, MacLeod W, Mkumla N, Orrell C, Jentsch U, Wallis CL, Stevens W, Wood R, Sanne I, Bhattacharya D.

PLoS One. 2013 Dec 6;8(12):e74900. doi: 10.1371/journal.pone.0074900. eCollection 2013.

14.

Cancer prevention by vaccination against hepatitis B.

Chang MH.

Recent Results Cancer Res. 2009;181:85-94. Review.

PMID:
19213561
15.

Current status of liver diseases in Korea: hepatocellular carcinoma.

Song IH, Kim KS.

Korean J Hepatol. 2009 Dec;15 Suppl 6:S50-9. doi: 10.3350/kjhep.2009.15.S6.S50. Review.

16.

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ; R.E.V.E.A.L.-HBV Study Group.

Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385.

PMID:
23504622
17.

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2012 May;142(5):1140-1149.e3; quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. Epub 2012 Feb 11.

PMID:
22333950
18.

Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ; Taiwan Community-Based Cancer Screening Project Group.

N Engl J Med. 2002 Jul 18;347(3):168-74.

19.

Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma.

Chang MH, Chen DS.

Baillieres Best Pract Res Clin Gastroenterol. 1999 Dec;13(4):511-7. Review.

PMID:
10654916
20.

Risk stratification for hepatitis B virus related hepatocellular carcinoma.

Lin CL, Kao JH.

J Gastroenterol Hepatol. 2013 Jan;28(1):10-7. doi: 10.1111/jgh.12010.

PMID:
23094699
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk